IL-9 and its receptor are predominantly involved in the pathogenesis of UC

Gut

Volumn 64, Issue 5, 2014, Pages 743-755

  Nalleweg, Nancy ^a   Chiriac, Mircea Teodor ^a,b,c   Podstawa, Eva ^a   Lehmann, Christian ^a   Rau, Tilman T ^a   Atreya, Raja ^a   Krauss, Ekaterina ^a   Hundorfean, Gheorghe ^a   Fichtner Feigl, Stefan ^d   Hartmann, Arndt ^a   Becker, Christoph ^a   Mudter, Jonas ^a,e  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Institute of Interdisciplinary Research in Bio Nano Sciences   (Romania)

^c BABE BOLYAI UNIVERSITY   (Romania)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e SANA KLINIKUM OFFENBACH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; BETA7 INTEGRIN; CALGRANULIN A; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; TRANSCRIPTION FACTOR PU 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; BETA INTEGRIN; CD3 ANTIGEN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; MESSENGER RNA; ONCOPROTEIN; PROTO-ONCOGENE PROTEIN SPI-1; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IL 9 GENE; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; MOLECULAR PATHOLOGY; PATHOGENESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEADY STATE; ULCERATIVE COLITIS; UPREGULATION; WOUND HEALING; ADOLESCENT; ADULT; AGED; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLOOD; CACO 2 CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; MALE; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; APOPTOSIS; CACO-2 CELLS; COLITIS, ULCERATIVE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN ALPHA4; INTEGRIN BETA CHAINS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-9; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTORS, INTERLEUKIN-9; RNA, MESSENGER; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTE SUBSETS; TRANS-ACTIVATORS; UP-REGULATION; WOUND HEALING; YOUNG ADULT;

EID: 84928584525     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305947     Document Type: Article

References (49)

1. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011;365:1713-25.
2. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
3. Neurath MF. Animal models of inflammatory bowel diseases: illuminating the pathogenesis of colitis, ileitis and cancer. Dig Dis 2012;30(Suppl 1):91-4.
4. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-90.
5. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005;129:550-64.
6. Heller F, Fuss IJ, Nieuwenhuis EE, et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002;17:629-38.
7. Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485-517.
8. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
9. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
10. Hundorfean G, Neurath MF, Mudter J. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm Bowel Dis 2012;18:180-6.
11. Kobayashi T, Okamoto S, Hisamatsu T, et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008;57:1682-9.
12. Kaplan MH. Th9 cells: differentiation and disease. Immunol Rev 2013;252:104-15.
13. Eyerich S, Eyerich K, Pennino D, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009;119:3573-85.
14. Wilhelm C, Hirota K, Stieglitz B, et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 2011;12:1071-7.
15. Wilhelm C, Turner JE, Van Snick J, et al. The many lives of IL-9: a question of survival? Nat Immunol 2012;13:637-41.
16. Dardalhon V, Awasthi A, Kwon H, et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008;9:1347-55.
17. Veldhoen M, Uyttenhove C, van Snick J, et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008;9:1341-6.
18. Goswami R, Jabeen R, Yagi R, et al. STAT6-dependent regulation of Th9 development. J Immunol 2012;188:968-75.
19. Staudt V, Bothur E, Klein M, et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010;33:192-202.
20. Chang HC, Sehra S, Goswami R, et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010;11:527-34.
21. Mudter J, Amoussina L, Schenk M, et al. The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. J Clin Invest 2008;118:2415-26.
22. Mudter J, Yu J, Zufferey C, et al. IRF4 regulates IL-17A promoter activity and controls RORgammat-dependent Th17 colitis in vivo. Inflamm Bowel Dis 2011;17:1343-58.
23. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133:1099-105; quiz 340-1.
24. Kim HS, Chung DH. IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner. Mucosal Immunol 2013;6:347-57.
25. Abdelilah S, Latifa K, Esra N, et al. Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release. J Immunol 2001;166:2768-74.
26. Amulic B, Cazalet C, Hayes GL, et al. Neutrophil function: from mechanisms to disease. Annu Rev Immunol 2012;30:459-89.
27. Danese S. New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 2012;61:918-32.
28. Schett G, Elewaut D, McInnes IB, et al. How Cytokine Networks Fuel Inflammation: toward a cytokine-based disease taxonomy. Nat Med 2013;19:822-4.
29. Fischer A, Gluth M, Pape UF, et al. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-alpha on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2013;304:G970-9.
30. Macdonald TT, Biancheri P, Sarra M, et al. What's the next best cytokine target in IBD? Inflamm Bowel Dis 2012;18:2180-9.
31. Coffman RL. Origins of the T(H)1-T(H)2 model: a personal perspective. Nat Immunol 2006;7:539-41.
32. Manolakis AC, Kapsoritakis AN, Tiaka EK, et al. Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Dig Dis Sci 2011;56:1601-11.
33. McNamara PS, Flanagan BF, Baldwin LM, et al. Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 2004;363:1031-7.
34. Putheti P, Awasthi A, Popoola J, et al. Human CD4 memory T cells can become CD4+IL-9+ T cells. PloS ONE 2010;5:e8706.
35. Schlapbach C, Gehad A, Yang C, et al. Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med 2014;6:219ra8.
36. Wong MT, Ye JJ, Alonso MN, et al. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol 2010;88:624-31.
37. Souza HS, Elia CC, Spencer J, et al. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 1999;45:856-63.
38. Feagan BG, Greenberg GR, Wild G, et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med 2005;352:2499-507.
39. Neurath MF. New targets for mucosal healing and therapy in inflammatory bowel diseases. Mucosal Immunol 2014;7:6-19.
40. Chang MS, Engel G, Benedict C, et al. Isolation and characterization of the human interleukin-9 receptor gene. Blood 1994;83:3199-205.
41. Girard D, Boiani N, Beaulieu AD. Human neutrophils express the interleukin-15 receptor alpha chain (IL-15Ralpha) but not the IL-9Ralpha component. Clin Immunol Immunopathol 1998;88:232-40.
42. Lampinen M, Sangfelt P, Taha Y, et al. Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment. Int J Colorectal Dis 2008;23:939-46.
43. Mantovani A, Cassatella MA, Costantini C, et al. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011;11:519-31.
44. Klein JB, Rane MJ, Scherzer JA, et al. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J Immunol 2000;164:4286-91.
45. Dong Q, Louahed J, Vink A, et al. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol 1999;29:2130-9.
46. Knoops L, Renauld JC. IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 2004;22:207-15.
47. Hubatsch I, Ragnarsson EG, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc 2007;2:2111-19.
48. Gesser B, Lund M, Lohse N, et al. IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. J Leukoc Biol 1996;59:407-11.
49. Erger RA, Casale TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol 1995;268:L117-22.